Zobacz wszystkie

myoscience: Justin Chickles Joins myoscience as Vice President of Commercial Development & Johanna Beckmen Becomes General Manager of Aesthetics

2014-08-06 14:00:00
Ticker Giełda ISIC Kraj Miasto
U.S.A. Redwood City, CA






REDWOOD CITY, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Myoscience, Inc. is

pleased to announce the addition of Justin Chickles to the team as Vice

President of Commercial Development and the promotion of Johanna Beckmen to

General Manager of Aesthetics.



Mr. Chickles was most recently the Director of Licensing and Business

Development at Purdue Pharma. Prior to Purdue Pharma, Mr. Chickles was a

Director at Johnson & Johnson, where he built an agile team dedicated to

creating a new market for a non-invasive device treating peripheral nerves.



"Myoscience's iovera° treatment is poised to become a transformative therapy for

patients living with pain," said Chickles. "The passion surrounding myoscience

is incredible. I've joined at a tipping point for the company and I am

enthusiastic about the potential in the therapeutic market."



Ms. Beckmen joined myoscience in June of 2013. In her tenure at myoscience, Ms.

Beckmen has been instrumental in developing the iovera° brand and social media

strategy. Previously, she had been responsible for the Thermage and Fraxel

brands at Solta Medical.



"We have made tremendous progress the past year in preparing for commercial

launch," said Clint Carnell, CEO of myoscience. "I am pleased to add such

talented individuals to lead our commercial efforts."



ABOUT MYOSCIENCE



Silicon Valley, California-based myoscience is a privately-held medical device

company committed to making its platform technology, Focused Cold Therapy(TM),

the standard of care for the treatment of peripheral nerve conditions. Focused

Cold Therapy is the patented technology delivered by the iovera? system. The

iovera? system is currently approved in Europe and Canada for temporary wrinkle

reduction, temporary pain reduction and treatment of dermatologic conditions,

and is indicated in the United States for use in pain management and general

surgical use. For more information, please visit www.myoscience.com.



The myoscience logo is available at

http://www.globenewswire.com/newsroom/prs/?pkgid=25085



? 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are

trademarks of myoscience.



MKT-0285 REV A



CONTACT: 1600 Seaport Blvd., Ste. 450 / Redwood City, CA

Tel: 650.474.2600 / iovera.com



MEDIA RELATIONS

Peter Osborne / posborne@myoscience.com









This announcement is distributed by GlobeNewswire on behalf of

GlobeNewswire clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and

other applicable laws; and

(ii) they are solely responsible for the content, accuracy and

originality of the information contained therein.



Source: myoscience via GlobeNewswire

[HUG#1846777]





podstrony